Rubella

Sabin and IPA Continue Advocacy Efforts Towards Measles and Rubella Elimination

03.14.13

From 19-22 February 2013, Sabin Executive Vice-President Dr. Ciro de Quadros and Program Officer Brian Shaw participated in the SEARO Regional Consultation on Measles Elimination and Rubella/CRS Control, held in Kathmandu, Nepal. As a member of the Measles Rubella Initiative (MRI), Sabin is committed to the elimination of measles, rubella & congenital rubella syndrome (CRS).

Rwanda first sub-Saharan African country to introduce measles-rubella vaccine

03.12.13

Rwanda’s measles-rubella vaccination campaign, which is being launched today, is the beginning of an effort to vaccinate more than 700 million children under 15 years of age against two disabling and deadly diseases.

Read more about Progress Toward Rubella Elimination and CRS Prevention in Europe

New York Times: After Measles Success, Rwanda to Get Rubella Vaccine

Submitted by Sabin on Wed, 2013-02-27 15:35

Rwanda has been so successful at fighting measles that next month it will be the first country to get donor support to move to the next stage — fighting rubella too.

Read more about New York Times: After Measles Success, Rwanda to Get Rubella Vaccine

Vaccine Information Session

10.24.12

São Paulo, Brazil

View event +

The Lancet: Reducing the global burden of congenital rubella syndrome

Submitted by Sabin on Sat, 2012-09-29 00:00

September 29, 2012 | The Lancet

Sabin Executive Vice President, Dr. Ciro de Quadros recently co-authored the following correspondence, which appeared in the September 29 edition of the Lancet.

Reducing the global burden of congenital rubella syndrome

Read more about The Lancet: Reducing the global burden of congenital rubella syndrome

Rubella and CRS Global Advocacy

Congenital Rubella Syndrome (CRS) causes severe growth and mental retardation, deafness and other developmental problems in developing fetuses. CRS is the result of infection by rubella (also known as German Measles) during the first trimester of pregnancy and, while the effects on the mother can be very mild, the effects on the developing fetus can be devastating. Though the burden of CRS is not well documented, the WHO estimates that in developing countries alone 100,000 cases of CRS occur each year.